ClinConnect ClinConnect Logo
Search / Trial NCT06852053

Application to Predict Neonatal Apnea With Bradycardia

Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Feb 24, 2025

Trial Information

Current as of July 01, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at ways to help pre-term infants who experience breathing pauses (called apnea) and slow heart rates (called bradycardia). The goal is to find out if gentle stimulation can help prevent these episodes from happening. This is important because apnea and bradycardia can be serious for newborns, especially those born early.

To participate in this study, infants must have had documented episodes of apnea with bradycardia in the past day and should not have been on breathing support for at least two days. They should also have been born at less than 32 weeks of gestation. Parents or legal guardians will need to give their permission for their baby to join the study. It’s important to note that babies with certain serious health conditions will not be eligible. The study is not currently recruiting participants, but it aims to provide valuable insights into improving care for these vulnerable infants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Documented episodes of apnea with bradycardia over the previous 24 hours.
  • Off ventilatory support/NCPAP for \> 48 hours prior to study entry
  • Gestational age \< 32 0/7 weeks' gestation at birth
  • Parents/legal guardians have provided consent for enrollment
  • Exclusion Criteria:
  • a major malformation or a neuromuscular condition that affects respiration or causes apnea, or terminal illness or decision to withhold or limit support.

About University Of Alabama At Birmingham

The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.

Locations

Birmingham, Alabama, United States

Patients applied

0 patients applied

Trial Officials

Colm P. Travers Associate Professor of Pediatrics, M.D.

Principal Investigator

University of Alabama at Birmingham

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported